Literature DB >> 7743307

Prognostic value of cholangiography in primary sclerosing cholangitis.

R G Olsson1, M S Asztély.   

Abstract

OBJECTIVE: To examine whether bile duct changes observed on the first diagnostic cholangiograms in patients with primary sclerosing cholangitis (PSC) can predict survival without liver transplantation and survival without symptoms of PSC.
DESIGN: Retrospective study. Findings from the first diagnostic cholangiograms were correlated with the time until the appearance of PSC symptoms and death.
SETTING: Primary and tertiary clinical care hospital. PATIENTS: Ninety-four patients with a diagnosis of PSC based on cholangiography. OUTCOME MEASURES: Time to death or liver transplantation and the first appearance of jaundice, upper abdominal pain, pruritus or fever.
RESULTS: Death or liver transplantation, as well as the occurrence of jaundice, were predicted by the grade of intrahepatic duct obstruction; whereas fever, pruritus and abdominal pain were predicted by the grade of extrahepatic duct obstruction.
CONCLUSIONS: High-grade intrahepatic strictures indicate early jaundice and short survival in patients with PSC. High-grade extrahepatic strictures indicate early pruritus, abdominal pain and fever of presumably PSC origin. The grade of intrahepatic strictures should be incorporated into survival models of PSC.

Entities:  

Mesh:

Year:  1995        PMID: 7743307

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

Review 1.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 2.  Role of endoscopy in primary sclerosing cholangitis.

Authors:  Nabeel S Koro; Samer Alkaade
Journal:  Curr Gastroenterol Rep       Date:  2013-12

Review 3.  Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

Authors:  Murad Aljiffry; Paul D Renfrew; Mark J Walsh; Marie Laryea; Michele Molinari
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

4.  Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.

Authors:  E Björnsson; K M Boberg; S Cullen; K Fleming; O P Clausen; O Fausa; E Schrumpf; R W Chapman
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

5.  A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis.

Authors:  Amaninder S Dhaliwal; Yassin Naga; Daryl Ramai; Syed M Saghir; Sarav G Daid; Banreet Dhindsa; Andrew Ofosu; Pushpak Taunk
Journal:  Ann Gastroenterol       Date:  2022-03-25

6.  Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.

Authors:  C Y Ponsioen; S M E Vrouenraets; W Prawirodirdjo; R Rajaram; E A J Rauws; C J J Mulder; J B Reitsma; S H Heisterkamp; G N J Tytgat
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 7.  Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.

Authors:  Kunjam Modha; Udayakumar Navaneethan
Journal:  World J Hepatol       Date:  2015-04-18

Review 8.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

9.  Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices.

Authors:  Moira B Hilscher; James H Tabibian; Elizabeth J Carey; Christopher J Gostout; Keith D Lindor
Journal:  Hepatol Commun       Date:  2018-05-04

10.  The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.

Authors:  Dan Segal; Paul Marotta; Mahmoud Mosli; Guangyong Zou; Brian G Feagan; Bandar Al-Judaibi
Journal:  Saudi J Gastroenterol       Date:  2019 May-Jun       Impact factor: 2.485

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.